|
US7105159B1
(en)
|
1992-11-05 |
2006-09-12 |
Sloan-Kettering Institute For Cancer Research |
Antibodies to prostate-specific membrane antigen
|
|
US7070782B1
(en)
|
1992-11-05 |
2006-07-04 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US6953668B1
(en)
|
1992-11-05 |
2005-10-11 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
|
US6569432B1
(en)
|
1995-02-24 |
2003-05-27 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
|
EP0812356B1
(en)
|
1995-02-24 |
2006-02-08 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
|
US6150508A
(en)
*
|
1996-03-25 |
2000-11-21 |
Northwest Biotherapeutics, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US6962981B1
(en)
|
1996-03-25 |
2005-11-08 |
Medarex, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US7381407B1
(en)
|
1996-03-25 |
2008-06-03 |
Medarex, Inc. |
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
|
|
US6136311A
(en)
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
|
US6107090A
(en)
|
1996-05-06 |
2000-08-22 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
|
|
US6207805B1
(en)
|
1997-07-18 |
2001-03-27 |
University Of Iowa Research Foundation |
Prostate cell surface antigen-specific antibodies
|
|
GB2328871A
(en)
*
|
1997-09-05 |
1999-03-10 |
Merck & Co Inc |
Compositions for inhibiting platelet aggregation
|
|
WO1999043710A1
(en)
*
|
1998-02-26 |
1999-09-02 |
Beckman Coulter, Inc. |
Prostate-specific membrane antigens and methods of making and using
|
|
IL139699A0
(en)
*
|
1998-06-01 |
2002-02-10 |
Urogenesys Inc |
Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
|
|
US20030035798A1
(en)
*
|
2000-08-16 |
2003-02-20 |
Fang Fang |
Humanized antibodies
|
|
SE9900495D0
(sv)
*
|
1999-02-12 |
1999-02-12 |
Pharmatrix Ab |
Vaccine composition
|
|
WO2000050457A1
(en)
*
|
1999-02-22 |
2000-08-31 |
Beckman Coulter, Inc. |
Prostate-specific membrane antigens and methods of making and using
|
|
MXPA02000961A
(es)
*
|
1999-07-29 |
2003-08-20 |
Medarex Inc |
Anticuerpos monoclonales humanos para antigeno de membrana especifico de la prostata.
|
|
EP1710256A1
(en)
*
|
1999-07-29 |
2006-10-11 |
Medarex, Inc. |
Human monoclonal antibodies to prostate specific membrane antigen
|
|
FR2797743B1
(fr)
*
|
1999-08-23 |
2003-08-08 |
Urogene |
Lignee cellulaire prostatique et son utilisation pour l'obtention d'une tumeur prostatique etablie chez l'animal
|
|
EP1221053A4
(en)
*
|
1999-09-13 |
2004-12-22 |
Neil H Bander |
METHOD FOR INSULATING PROSTATIC EPITHELIC CELLS FROM SPERM
|
|
JP4838436B2
(ja)
*
|
2001-04-04 |
2011-12-14 |
積水メディカル株式会社 |
抗ヒト肝性トリグリセリドリパーゼ抗体
|
|
IL158969A0
(en)
|
2001-06-01 |
2004-05-12 |
Cornell Res Foundation Inc |
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
|
US7514078B2
(en)
|
2001-06-01 |
2009-04-07 |
Cornell Research Foundation, Inc. |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
|
|
AU2002305767B2
(en)
|
2001-09-20 |
2008-04-10 |
Cornell Research Foundation, Inc. |
Methods and compositions for treating and preventing skin disorders using binding agents specific for PSMA
|
|
EP1448588A4
(en)
|
2001-10-23 |
2006-10-25 |
Psma Dev Company L L C |
ANTIBODIES AND MULTIMERS OF PSMA PROTEINS
|
|
US20040161776A1
(en)
*
|
2001-10-23 |
2004-08-19 |
Maddon Paul J. |
PSMA formulations and uses thereof
|
|
US20050215472A1
(en)
|
2001-10-23 |
2005-09-29 |
Psma Development Company, Llc |
PSMA formulations and uses thereof
|
|
EP1581794B1
(en)
|
2003-01-10 |
2008-09-17 |
Millennium Pharmaceuticals, Inc. |
Method of determining risk for prostate cancer recurrence
|
|
WO2006089231A2
(en)
|
2005-02-18 |
2006-08-24 |
Medarex, Inc. |
Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues
|
|
EP1863848A4
(en)
*
|
2005-03-31 |
2009-09-23 |
Agensys Inc |
CORRESPONDING ANTIBODIES AND MOLECULES THAT ATTACH PROTEINS 161P2F10B
|
|
EP1726650A1
(en)
*
|
2005-05-27 |
2006-11-29 |
Universitätsklinikum Freiburg |
Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
|
|
EP1934261B1
(en)
|
2005-09-26 |
2014-10-29 |
Medarex, L.L.C. |
Human monoclonal antibodies to cd70
|
|
WO2007109321A2
(en)
|
2006-03-20 |
2007-09-27 |
The Regents Of The University Of California |
Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
|
|
US8940298B2
(en)
|
2007-09-04 |
2015-01-27 |
The Regents Of The University Of California |
High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection
|
|
WO2009106101A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Interuniversitair Microelektronica Centrum |
Cell-enzyme based biosensors
|
|
WO2010027513A2
(en)
|
2008-09-08 |
2010-03-11 |
Psma Development Company, Llc |
Methods for killing psma-expressing, taxane-resistant cancer cells
|
|
US10517969B2
(en)
|
2009-02-17 |
2019-12-31 |
Cornell University |
Methods and kits for diagnosis of cancer and prediction of therapeutic value
|
|
US8772459B2
(en)
|
2009-12-02 |
2014-07-08 |
Imaginab, Inc. |
J591 minibodies and Cys-diabodies for targeting human prostate specific membrane antigen (PSMA) and methods for their use
|
|
RU2610336C2
(ru)
|
2011-04-21 |
2017-02-09 |
Сиэтл Дженетикс, Инк. |
Новые конъюгаты связывающее соединение - активное соединение (adc) и их применение
|
|
RU2632647C2
(ru)
|
2011-04-22 |
2017-10-06 |
Аптево Рисерч Энд Девелопмент Ллс |
Белки, связывающие специфический мембранный антиген простаты, и соответствующие композиции и способы
|
|
PE20160996A1
(es)
|
2013-12-23 |
2016-11-09 |
Bayer Pharma AG |
Conjugados de farmacos anticuerpo (adcs) con inhibidores de ksp
|
|
CN108025084B
(zh)
|
2015-06-22 |
2024-08-09 |
拜耳医药股份有限公司 |
具有酶可裂解基团的抗体药物缀合物（adc）和抗体前药缀合物（apdc）
|
|
JOP20160154B1
(ar)
|
2015-07-31 |
2021-08-17 |
Regeneron Pharma |
أجسام ضادة مضاد لل psma، وجزيئات رابطة لمستضد ثنائي النوعية الذي يربط psma و cd3، واستخداماتها
|
|
NZ739721A
(en)
|
2015-08-07 |
2019-09-27 |
Imaginab Inc |
Antigen binding constructs to target molecules
|
|
CN108367004B
(zh)
|
2015-09-21 |
2022-09-13 |
阿帕特夫研究和发展有限公司 |
Cd3结合多肽
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
CA3018630A1
(en)
|
2016-03-24 |
2017-09-28 |
Bayer Pharma Aktiengesellschaft |
Prodrugs of cytotoxic active agents having enzymatically cleavable groups
|
|
EP3919518A1
(en)
|
2016-06-15 |
2021-12-08 |
Bayer Pharma Aktiengesellschaft |
Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodies
|
|
RU2761390C2
(ru)
|
2016-12-21 |
2021-12-07 |
Байер Фарма Акциенгезельшафт |
Конъюгаты связующего и активного вещества (adc), имеющие ферментативно расщепляемые группы
|
|
CN110072556B
(zh)
|
2016-12-21 |
2023-05-02 |
拜耳制药股份公司 |
具有ksp抑制剂的特异性抗体药物缀合物(adc)
|
|
JP7174704B2
(ja)
|
2016-12-21 |
2022-11-17 |
バイエル・アクチエンゲゼルシヤフト |
酵素開裂基を有する細胞毒性活性剤のプロドラッグ
|
|
EP3762410A4
(en)
|
2018-03-06 |
2022-04-06 |
The Trustees of the University of Pennsylvania |
CHEMICAL PROSTATE MEMBRANE SPECIFIC ANTIGEN SPECIFIC ANTIGEN RECEPTORS AND METHODS OF USE THEREOF
|
|
CN112469440B
(zh)
|
2018-06-18 |
2024-09-06 |
优瑞科生物技术公司 |
靶向前列腺特异性膜抗原(psma)的构建体和其用途
|
|
IL279823B1
(en)
|
2018-07-31 |
2025-10-01 |
Heidelberg Pharma Res Gmbh |
Cultured antibodies against PSMA
|